Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATROPIN: Atropine for Sacituzumab Govitecan Tolerance in Advanced Breast Cancer
NCT07367178Phase 2Not yet recruiting
- Sponsor
- MEDSIR
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of atropine in diarrhea, sponsored by MEDSIR. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT07367178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07367178.